1. Home
  2. BIO vs CRL Comparison

BIO vs CRL Comparison

Compare BIO & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIO
  • CRL
  • Stock Information
  • Founded
  • BIO 1952
  • CRL 1947
  • Country
  • BIO United States
  • CRL United States
  • Employees
  • BIO N/A
  • CRL N/A
  • Industry
  • BIO Biotechnology: Laboratory Analytical Instruments
  • CRL Biotechnology: Commercial Physical & Biological Resarch
  • Sector
  • BIO Industrials
  • CRL Health Care
  • Exchange
  • BIO Nasdaq
  • CRL Nasdaq
  • Market Cap
  • BIO 9.1B
  • CRL 9.8B
  • IPO Year
  • BIO N/A
  • CRL 2000
  • Fundamental
  • Price
  • BIO $327.15
  • CRL $185.77
  • Analyst Decision
  • BIO Strong Buy
  • CRL Hold
  • Analyst Count
  • BIO 4
  • CRL 13
  • Target Price
  • BIO $414.00
  • CRL $211.64
  • AVG Volume (30 Days)
  • BIO 203.8K
  • CRL 552.8K
  • Earning Date
  • BIO 02-13-2025
  • CRL 02-12-2025
  • Dividend Yield
  • BIO N/A
  • CRL N/A
  • EPS Growth
  • BIO N/A
  • CRL N/A
  • EPS
  • BIO N/A
  • CRL 8.00
  • Revenue
  • BIO $2,580,209,000.00
  • CRL $4,060,916,000.00
  • Revenue This Year
  • BIO N/A
  • CRL N/A
  • Revenue Next Year
  • BIO $2.92
  • CRL $1.18
  • P/E Ratio
  • BIO N/A
  • CRL $23.22
  • Revenue Growth
  • BIO N/A
  • CRL N/A
  • 52 Week Low
  • BIO $262.12
  • CRL $176.48
  • 52 Week High
  • BIO $387.99
  • CRL $275.00
  • Technical
  • Relative Strength Index (RSI)
  • BIO 44.03
  • CRL 42.07
  • Support Level
  • BIO $318.27
  • CRL $180.21
  • Resistance Level
  • BIO $351.08
  • CRL $199.45
  • Average True Range (ATR)
  • BIO 11.74
  • CRL 6.38
  • MACD
  • BIO -0.86
  • CRL -1.47
  • Stochastic Oscillator
  • BIO 27.06
  • CRL 24.70

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

About CRL Charles River Laboratories International Inc.

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.

Share on Social Networks: